300406 九強生物
按盤價 
12.760 +1.030 (+8.781%)
12.760 +1.030 (+8.781%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.750 | 4.799 | 13.716 | 14.973 | 12.663 |
| 總資產報酬率 ROA (%) | 2.064 | 3.578 | 10.027 | 10.701 | 8.712 |
| 投入資產回報率 ROIC (%) | 2.135 | 3.724 | 10.548 | 11.269 | 9.230 | 邊際利潤分析 |
| 銷售毛利率 (%) | 81.939 | 79.349 | 78.498 | 74.664 | 74.590 |
| 營業利潤率 (%) | 37.019 | 17.409 | 37.618 | 34.099 | 30.147 |
| 息稅前利潤/營業總收入 (%) | 40.295 | 20.433 | 39.693 | 36.504 | 32.932 |
| 淨利潤/營業總收入 (%) | 31.544 | 14.057 | 32.359 | 29.976 | 26.108 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.567 | 180.203 | 97.117 | 99.276 | 104.893 |
| 價值變動淨收益/利潤總額(%) | 2.956 | 5.137 | 1.549 | 3.498 | 4.245 |
| 營業外收支淨額/利潤總額(%) | 0.034 | 0.114 | -0.542 | -0.054 | -1.365 | 償債能力分析 |
| 流動比率 (X) | 12.177 | 12.840 | 9.280 | 7.856 | 6.936 |
| 速動比率 (X) | 11.197 | 11.748 | 8.486 | 7.083 | 6.199 |
| 資產負債率 (%) | 25.038 | 25.128 | 25.932 | 28.096 | 29.138 |
| 帶息債務/全部投入資本 (%) | 21.673 | 21.725 | 21.626 | 23.251 | 25.034 |
| 股東權益/帶息債務 (%) | 358.373 | 357.066 | 358.889 | 327.415 | 296.779 |
| 股東權益/負債合計 (%) | 299.852 | 298.370 | 286.005 | 256.127 | 243.373 |
| 利息保障倍數 (X) | 12.345 | 6.802 | 17.424 | 15.064 | 10.321 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 276.861 | 277.174 | 236.375 | 218.230 | 229.676 |
| 存貨周轉天數 (天) | 279.910 | 262.228 | 227.297 | 183.318 | 221.139 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/04/2026 14:24 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
